03 December 2013 - 04 December 2013
Optimisation of the cold chain is imperative for the successful organization and distribution of a variety of pharmaceutical drugs and products. Continual discussion and development in all aspects of the cold chain is critical for this improvement. Building on the very successful 2012 event this year’s conference will draw from the expertise of industry specialists, pharmaceuticals, suppliers, and academia. This will provide excellent opportunities for personal and business development, while striking first-class discussion on the field's hottest topics and challenges.
Marriott Regents Park Hotel, London, UK
08 December 2013 - 12 December 2013
Now in its 24th year, Antibody Engineering & Therapeutics has earned its reputation by consistently offering the most current academic research findings and most recent industry updates. Our attendees come back year after year for the information they need to stay abreast of the latest scientific trends in the antibody field. World-renowned scientists from across the globe convene at this event to share best practices and new approaches to exploit antibodies for developing novel medicines and vaccines. Learn about both the basic science of antibody engineering and the latest preclinical/clinical data, including safety and efficacy studies of the most cutting-edge antibody therapeutics now in development.
Hyatt Regency Huntington Beach Resort & Spa • Huntington Beach, CA, USA
09 December 2013 - 13 December 2013
This joint EBI-Wellcome Trust course aims to provide participants with the principles of computational chemical biology and how to use computational methods to probe, explore and modulate biological systems using chemical tools. The course will be comprised of a mixture of lectures and hands-on exercises. The conceptual framework will be covered along with direct practical experience of retrieving and analysing chemogenomics data. Participants will be able to do their own target analysis and identify appropriate chemical tools for probing biological systems of personal interest.
Wellcome Trust Genome Campus, Hinxton, Cambridge, UK
12 December 2013
New drug discovery strategies, facilitated by technological advances, have evolved rapidly in recent years. Drug researchers are now pushing the drug discovery envelope, particularly in the fields of hit identification, prosecution of new targets and exploration of novel chemical space. This meeting brings together experts to highlight several of these developments describing work from hit identification through to candidate selection and beyond. Themes covered include the application of fragment based drug discovery to new target classes, antibodies in drug discovery, defining new chemical space with macrocycles and non-macrocycles, the renewed importance of phenotypic screening and approaches for the identification of allosteric modulators. The meeting will be of great interest to all involved in cutting edge drug discovery.
The National Heart and Lung Institute, Kensington, London
© 2013 Bioscreening.com